Rosiglitazone May Help Maintain Cognition in Diabetes Patients

FRIDAY, Aug. 6 (HealthDay News) -- Adding rosiglitazone to the treatment for type 2 diabetes may help protect against cognitive decline in older patients with mild cognitive impairment, according to a study in the August issue of Diabetes Care.